0001209191-16-151999.txt : 20161123 0001209191-16-151999.hdr.sgml : 20161123 20161123183347 ACCESSION NUMBER: 0001209191-16-151999 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161122 FILED AS OF DATE: 20161123 DATE AS OF CHANGE: 20161123 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ChemoCentryx, Inc. CENTRAL INDEX KEY: 0001340652 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943254365 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-210-2900 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bekker Petrus CENTRAL INDEX KEY: 0001422997 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35420 FILM NUMBER: 162017526 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-11-22 0 0001340652 ChemoCentryx, Inc. CCXI 0001422997 Bekker Petrus C/O CHEMOCENTRYX, INC. 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 0 1 0 0 Chief Medical Officer Common Stock 2016-11-22 4 M 0 1250 6.30 A 54844 D Common Stock 2016-11-22 4 S 0 1250 8.30 D 53594 D Stock Option (right to buy) 6.30 2016-11-22 4 M 0 1250 D 2010-08-10 2020-08-10 Common Stock 1250 47760 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. As of November 22, 2016 and prior to this transaction, the option fully vested Not applicable. /s/ Susan M. Kanaya, as Attorney-in-Fact 2016-11-23